GenMark Diagnostics to Report Second Quarter 2020 Financial Results on August 4, 2020

Rhea-AI Summary

GenMark Diagnostics (NASDAQ: GNMK) will release its second quarter earnings on August 4, 2020, after market close. A conference call will follow at 1:30 p.m. PT to discuss financial performance, with a simultaneous webcast available on their website. GenMark specializes in multiplex molecular diagnostic solutions, enhancing patient care and reducing total care costs. Their eSensor technology supports various diagnostic tests efficiently, addressing infectious disease testing needs.

Positive

• GenMark's ePlex™ system enhances laboratory efficiency for infectious disease testing.

Negative

• None.

CARLSBAD, Calif., July 21, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its second quarter earnings results after market close on Tuesday, August 4, 2020. Management will hold a conference call to review the company's financial performance starting at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on the same day. The conference call will be concurrently webcast.

The link to the webcast will be available on the GenMark Diagnostics, Inc. website at www.genmarkdx.com under the investor relations section and will be archived for future reference. To listen to the conference call, please dial (877) 312-5847 (US/Canada) or (253) 237-1154 (International) and use the conference ID number 1067506 approximately ten minutes prior to the start time.

ABOUT GENMARK DIAGNOSTICS
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care. Utilizing GenMark's proprietary eSensor^® detection technology, GenMark's eSensor XT-8^® and ePlex^® systems are designed to support a broad range of molecular diagnostic tests with compact, easy-to-use workstations and self-contained, disposable test cartridges. GenMark’s ePlex: The True Sample-to-Answer Solution^™ is designed to optimize laboratory efficiency and address a broad range of infectious disease testing needs, including respiratory, bloodstream, and gastrointestinal infections. For more information, visit www.genmarkdx.com.

Investor Relations Contact
Leigh Salvo
(415) 937-5404
ir@genmarkdx.com

FAQ

When will GenMark Diagnostics announce its second quarter earnings?

GenMark Diagnostics will announce its second quarter earnings on August 4, 2020.

What time is the GenMark conference call for the second quarter earnings?

The conference call will start at 1:30 p.m. PT on August 4, 2020.

How can I access the GenMark Diagnostics earnings call?

You can access the earnings call by dialing (877) 312-5847 for US/Canada or (253) 237-1154 internationally and using conference ID 1067506.

What technology does GenMark Diagnostics use for molecular diagnostics?

GenMark uses proprietary eSensor® detection technology for its molecular diagnostic solutions.